Two New PBMs Promise Patient Centricity and Pricing Transparency

EmsanaRx and Mark Cuban’s Cost Plus startup are the latest pharmacy benefit management (PBM) companies promising transparency and a patient-centered approach. Critics remain skeptical.

“CostPlus PBM will begin serving clients in plan year 2023, while EmsanaRx will serve some clients starting in plan year 2022…CostPlus PBM has aggressive growth targets: Its CEO, Alex Oshmyansky, M.D., Ph.D., tells AIS Health, a division of MMIT, that the company will “absolutely” seek to grow to Big Three size.” Read more here.

(Source: AIS Health, 10/28/21)